Who Owns Alvotech Stock?
NASDAQ: ALVOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 12.80%
- Held by insiders
- 59.68%
- Institutional holders
- 104
- Institutions 12.8%
- Insiders 59.7%
- Public and other 27.5%
Who owns Alvotech stock?
Institutional investors own about 12.8% of Alvotech's shares, spread across 104 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 59.68% of ALVO.
The largest institutional holders are Rubric Capital Management LP (5.02%), Millennium Management Llc (1.37%) and Bracebridge Capital, LLC (1.29%). Together, the top 10 institutions control 11.9% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their ALVO positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ALVO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Rubric Capital Management LP | 15.68M | 5.02% | +100.0% |
| Millennium Management Llc | 4.26M | 1.37% | +100.9% |
| Bracebridge Capital, LLC | 4.04M | 1.29% | +49.3% |
| Vanguard Capital Management LLC | 3.69M | 1.18% | +8.2% |
| Farallon Capital Management LLC | 2.86M | 0.92% | +1332.2% |
| Citadel Advisors Llc | 1.73M | 0.55% | +100.0% |
| Price (T.Rowe) Associates Inc | 1.42M | 0.45% | +1.5% |
| Blackrock Inc. | 1.33M | 0.43% | +6.6% |
| Littlejohn & Co LLC | 1.32M | 0.42% | 0.0% |
| Vanguard Fiduciary Trust Co | 998.60K | 0.32% | +2.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ALVO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund | 1.67M | 0.54% |
| VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd | 1.61M | 0.52% |
| T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Discovery Fd. | 1.12M | 0.36% |
| iShares Trust-iShares Biotechnology ETF | 1.05M | 0.34% |
| Global Macro Absolute Return Advantage Portfolio | 593.15K | 0.19% |
| ROYCE FUND-Royce Smaller-Companies Growth Fund | 523.96K | 0.17% |
| iShares Trust-iShares Genomics Immunology and Healthcare ETF | 271.88K | 0.09% |
| VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd. | 257.26K | 0.08% |
| TR PRICE-Price (T.Rowe) International Small-Cap Equity Trust | 250.64K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 192.74K | 0.06% |
Frequently asked questions
Who is the largest shareholder of Alvotech?
Rubric Capital Management LP is the largest institutional shareholder of ALVO, owning 5.02% of shares outstanding (15.68M shares) as of its latest 13F filing.
What percentage of Alvotech is owned by institutions?
Institutions own about 12.8% of ALVO shares and 31.8% of the public float.
How much of Alvotech do insiders own?
Insiders, such as officers and directors, own about 59.68% of ALVO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.